Table 3.

Morbid risk (per 100 participants) at 75 and ratio of morbid risk/lifetime prevalence by sex

	Morbid risk (per 100 participants at age 75)				Ratio of morbid risk to lifetime prevalence
	Male		Female		Male		Female
Lifetime disorder	MR	(95% CI)	MR	(95% CI)	MR/LP	(95% CI)	MR/LP	(95% CI)
I. Anxiety disorders
Panic disorder and/or agoraphobia	3·6	(3·2-3·9)	7·3	(6·8-7·8)	1·8	(1·7-2·0)	2·0	(1·9-2·0)
Generalized anxiety disorder	6·5	(5·9-7·0)	12·5	(11·8-13·2)	2·4	(2·2-2·5)	2·5	(2·4-2·6)
Post-traumatic stress disorder	5·7	(5·1-6·3)	12·6	(11·7-13·5)	2·1	(1·9-2·2)	2·3	(2·2-2·4)
Social phobia	4·2	(3·8-4·6)	6·0	(5·5-6·4)	1·2	(1·1-1·3)	1·3	(1·2-1·4)
Specific phobia	5·9	(5·3-6·5)	11·6	(10·9-12·2)	1·2	(1·1-1·2)	1·2	(1·1-1·2)
Any anxiety disorder	18·3	(17·3-19·4)	31·0	(29·9-32·2)	1·6	(1·6-1·7)	1·7	(1·6-1·7)
II. Mood disorders
Major depressive disorder	20·1	(19·2-20·9)	34·0	(33·2-34·9)	2·7	(2·6-2·8)	2·5	(2·4-2·5)
Bipolar disorder	6·3	(5·7-6·8)	6·2	(5·7-6·7)	2·5	(2·3-2·6)	2·8	(2·6-2·9)
Any mood disorder	24·5	(23·5-25·4)	37·9	(37·0-38·8)	2·6	(2·5-2·7)	2·5	(2·4-2·5)
III. Substance use disorder
Alcohol abuse disorder	21·6	(20·6-22·7)	7·2	(6·7-7·7)	1·6	(1·5-1·6)	2·2	(2·1-2·3)
Alcohol dependence	6·1	(5·6-6·7)	2·3	(2·0-2·7)	1·8	(1·7-1·9)	2·4	(2·2-2·7)
Drug abuse disorder	7·9	(7·2-8·7)	4·2	(3·8-4·7)	1·9	(1·8-2·1)	2·5	(2·3-2·7)
Drug dependence	3·0	(2·4-3·5)	1·6	(1·4-1·9)	2·1	(1·8-2·3)	2·5	(2·3-2·8)
Any substance use disorder	24·4	(23·3-25·6)	9·9	(9·2-10·5)	1·6	(1·5-1·6)	2·2	(2·1-2·3)
IV. Externalizing disorders
Attention deficit/hyperactivity disorder	3·0	(2·4-3·6)	1·8	(1·4-2·2)	1·3	(1·1-1·4)	1·2	(1·1-1·4)
Intermittent explosive disorder	5·9	(5·2-6·5)	5·2	(4·7-5·8)	1·7	(1·6-1·8)	2·1	(1·9-2·2)
Any externalizing disorder	6·8	(6·0-7·5)	5·6	(5·0-6·2)	1·6	(1·5-1·7)	1·8	(1·7-1·9)
V. Any mental disorder	46·4	(44·9-47·8)	53·1	(51·9-54·3)	1·6	(1·6-1·7)	1·8	(1·8-1·8)

Abbreviations: MR, morbid risk per 100 participants; 95% CI, 95% confidence interval of MR; MR/LP, ratio of MR to lifetime prevalence as of age 75.